Published in Br J Pharmacol on November 06, 2006
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci (2011) 2.82
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (2008) 2.42
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11
The Concise Guide to PHARMACOLOGY 2013/14: transporters. Br J Pharmacol (2013) 2.07
Targeting astrocyte signaling for chronic pain. Neurotherapeutics (2010) 1.88
Glial cells physiologically modulate clock neurons and circadian behavior in a calcium-dependent manner. Curr Biol (2011) 1.80
Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. Nat Neurosci (2009) 1.70
Amino acid transceptors: gate keepers of nutrient exchange and regulators of nutrient signaling. Am J Physiol Endocrinol Metab (2009) 1.68
Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci (2010) 1.64
Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol (2011) 1.50
Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport. Proc Natl Acad Sci U S A (2009) 1.49
GLAST stability and activity are enhanced by interaction with the PDZ scaffold NHERF-2. Neurosci Lett (2010) 1.43
A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience (2008) 1.34
Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol (2010) 1.31
System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol (2012) 1.27
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry (2013) 1.21
Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev (2012) 1.21
Overview of glutamatergic neurotransmission in the nervous system. Pharmacol Biochem Behav (2011) 1.18
Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Mol Pain (2008) 1.14
Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment. Br J Pharmacol (2010) 1.11
Glutamate transporter 1: target for the treatment of alcohol dependence. Curr Med Chem (2012) 1.09
GABA and Glutamate Transporters in Brain. Front Endocrinol (Lausanne) (2013) 1.06
Review part 2: Human herpesvirus-6 in central nervous system diseases. J Med Virol (2010) 1.05
Regulation of synaptic transmission by ambient extracellular glutamate. Neuroscientist (2007) 1.05
L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation. J Neuroinflammation (2012) 1.02
Glutamate uptake triggers transporter-mediated GABA release from astrocytes. PLoS One (2009) 1.01
Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection. J Neurosci (2011) 0.98
Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther (2009) 0.96
Internalization and degradation of the glutamate transporter GLT-1 in response to phorbol ester. Neurochem Int (2007) 0.96
Evidence for glutamate as a neuroglial transmitter within sensory ganglia. PLoS One (2013) 0.96
Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells. J Cereb Blood Flow Metab (2011) 0.96
Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes. J Neurosci (2011) 0.95
Up-regulation of spinal glutamate transporters contributes to anti-hypersensitive effects of valproate in rats after peripheral nerve injury. Neurosci Lett (2011) 0.94
Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. Brain Res (2012) 0.94
The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes. Br J Pharmacol (2011) 0.93
The four major N- and C-terminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies. Mol Pharmacol (2009) 0.90
Phylogenetic analysis of the vertebrate excitatory/neutral amino acid transporter (SLC1/EAAT) family reveals lineage specific subfamilies. BMC Evol Biol (2010) 0.89
Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3. Bioorg Med Chem (2008) 0.88
Riluzole elevates GLT-1 activity and levels in striatal astrocytes. Neurochem Int (2011) 0.87
Astroglial glutamate transporters coordinate excitatory signaling and brain energetics. Neurochem Int (2016) 0.86
Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion. Br J Pharmacol (2010) 0.86
Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-β1 in the CNS. Glia (2013) 0.85
GLT-1 Promoter Activity in Astrocytes and Neurons of Mouse Hippocampus and Somatic Sensory Cortex. Front Neuroanat (2010) 0.85
Reduction of EEG theta power and changes in motor activity in rats treated with ceftriaxone. PLoS One (2012) 0.85
Cellular and Synaptic Localization of EAAT2a in Human Cerebral Cortex. Front Neuroanat (2011) 0.84
Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1. J Neuroinflammation (2011) 0.84
Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications. AJNR Am J Neuroradiol (2011) 0.83
SLC1 glutamate transporters. Pflugers Arch (2013) 0.83
Time-dependent modulation of AMPA receptor phosphorylation and mRNA expression of NMDA receptors and glial glutamate transporters in the rat hippocampus and cerebral cortex in a pilocarpine model of epilepsy. Exp Brain Res (2013) 0.83
Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice. J Biol Chem (2013) 0.82
Neuronal influences are necessary to produce mitochondrial co-localization with glutamate transporters in astrocytes. J Neurochem (2014) 0.81
Physical and functional interaction of NCX1 and EAAC1 transporters leading to glutamate-enhanced ATP production in brain mitochondria. PLoS One (2012) 0.81
Cardiac glycosides ouabain and digoxin interfere with the regulation of glutamate transporter GLAST in astrocytes cultured from neonatal rat brain. Neurochem Res (2010) 0.81
Treating seizures and epilepsy with anticoagulants? Front Cell Neurosci (2013) 0.81
Thrombin regulation of synaptic transmission and plasticity: implications for health and disease. Front Cell Neurosci (2015) 0.80
Pre-ischemic treadmill training for prevention of ischemic brain injury via regulation of glutamate and its transporter GLT-1. Int J Mol Sci (2012) 0.80
From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition. Mol Autism (2016) 0.80
Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration. J Biol Chem (2013) 0.80
An association between the reduced levels of SLC1A2 and GAD1 in the dorsolateral prefrontal cortex in major depressive disorder: possible involvement of an attenuated RAF/MEK/ERK signaling pathway. J Neural Transm (Vienna) (2014) 0.80
The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats. Neuropsychopharmacology (2010) 0.80
Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury. J Pain (2013) 0.80
Extracellular microvesicles from astrocytes contain functional glutamate transporters: regulation by protein kinase C and cell activation. Front Cell Neurosci (2013) 0.80
Etomidate reduces glutamate uptake in rat cultured glial cells: involvement of PKA. Br J Pharmacol (2008) 0.79
Increased excitatory amino acid transport into murine prion protein knockout astrocytes cultured in vitro. Glia (2011) 0.79
Impairment of neuronal glutamate uptake and modulation of the glutamate transporter GLT-1 induced by retinal ischemia. PLoS One (2013) 0.79
Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. BMC Neurosci (2012) 0.79
The rates of postmortem proteolysis of glutamate transporters differ dramatically between cells and between transporter subtypes. J Histochem Cytochem (2012) 0.79
Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain. Front Microbiol (2016) 0.78
The chemokine, macrophage inflammatory protein-2γ, reduces the expression of glutamate transporter-1 on astrocytes and increases neuronal sensitivity to glutamate excitotoxicity. J Neuroinflammation (2012) 0.78
Gene therapy: a potential approach for cancer pain. Pain Res Treat (2011) 0.78
Potential therapeutic role of glutamate transporter 1 for the treatment of alcohol dependence. OA Alcohol (2013) 0.78
Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat. Cell Mol Neurobiol (2014) 0.78
EAAT2 (GLT-1; slc1a2) glutamate transporters reconstituted in liposomes argues against heteroexchange being substantially faster than net uptake. J Neurosci (2014) 0.78
Distribution of Na,K-ATPase α subunits in rat vestibular sensory epithelia. J Assoc Res Otolaryngol (2014) 0.78
Transcriptomic analysis and 3D bioengineering of astrocytes indicate ROCK inhibition produces cytotrophic astrogliosis. Front Neurosci (2015) 0.77
Muscarinic receptor stimulation of D-aspartate uptake into human SH-SY5Y neuroblastoma cells is attenuated by hypoosmolarity. J Pharmacol Exp Ther (2010) 0.77
Neuroprotective role of liver growth factor "LGF" in an experimental model of cerebellar ataxia. Int J Mol Sci (2014) 0.77
Differential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-α in cortical astrocytes from a rat model of amyotrophic lateral sclerosis. PLoS One (2014) 0.77
Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors. Adv Pharmacol (2016) 0.76
Neuroproteome changes after ischemia/reperfusion injury and tissue plasminogen activator administration in rats: a quantitative iTRAQ proteomics study. PLoS One (2014) 0.76
Estrogen attenuates manganese-induced glutamate transporter impairment in rat primary astrocytes. Neurotox Res (2012) 0.76
Sonic hedgehog is a regulator of extracellular glutamate levels and epilepsy. EMBO Rep (2016) 0.76
Discovery of a Tamoxifen-related compound that suppresses glial l-glutamate transport activity without interaction with estrogen receptors. ACS Chem Neurosci (2011) 0.75
Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus. Psychopharmacology (Berl) (2015) 0.75
Lesion-induced alterations in astrocyte glutamate transporter expression and function in the hippocampus. ISRN Neurol (2013) 0.75
O brother, wherefore are thou? Calcium-permeable AMPA receptors make an appearance in adult status epilepticus. Epilepsy Curr (2013) 0.75
Corticostriatal Dysfunction in Huntington's Disease: The Basics. Front Hum Neurosci (2016) 0.75
Effects of 3 weeks GMP oral administration on glutamatergic parameters in mice neocortex. Purinergic Signal (2011) 0.75
Involvement of the glutamate/glutamine cycle and glutamate transporter GLT-1 in antidepressant-like effects of Xiao Yao san on chronically stressed mice. BMC Complement Altern Med (2017) 0.75
Different AMPA receptor subtypes mediate the distinct kinetic components of a biphasic EPSC in hippocampal interneurons. Front Synaptic Neurosci (2015) 0.75
The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element. J Neurochem (2015) 0.75
4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. J Alzheimers Dis (2012) 0.75
Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia. Mol Neuropsychiatry (2015) 0.75
Inhibitory effect of yokukansan on the decrease in the hippocampal excitatory amino acid transporter EAAT2 in stress-maladaptive mice. J Tradit Complement Med (2017) 0.75
Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4. J Membr Biol (2015) 0.75
Rho GTPases and the actin cytoskeleton. Science (1998) 28.19
Glutamate uptake. Prog Neurobiol (2001) 13.59
Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol (2003) 9.85
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature (2005) 7.19
Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature (2004) 6.02
Astrocyte activation and reactive gliosis. Glia (2005) 5.46
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci (2003) 4.50
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A (2002) 4.37
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med (1992) 3.71
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol (1995) 3.66
VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci (2004) 3.45
Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet (1993) 3.27
DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol (1998) 2.93
Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci U S A (1997) 2.86
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov (2002) 2.85
Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature (2000) 2.78
Transporters buffer synaptically released glutamate on a submillisecond time scale. J Neurosci (1997) 2.74
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron (1998) 2.45
Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet (2006) 2.34
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci (2005) 2.31
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain (2005) 2.17
The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J Neurochem (1972) 2.15
Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex. Neuron (2003) 2.11
Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci (1999) 1.94
Small-scale molecular motions accomplish glutamate uptake in human glutamate transporters. J Neurosci (2005) 1.93
Differential gene expression profiling in human brain tumors. Physiol Genomics (2001) 1.88
The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J Neurosci (2004) 1.82
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev (2004) 1.81
Individual subunits of the glutamate transporter EAAC1 homotrimer function independently of each other. Biochemistry (2005) 1.81
Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol (2001) 1.78
Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology (1999) 1.77
The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch (2003) 1.75
Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics. J Neurochem (2005) 1.73
Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis (2001) 1.71
Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain (2002) 1.71
Patterned expression of Purkinje cell glutamate transporters controls synaptic plasticity. Nat Neurosci (2005) 1.69
Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol (1996) 1.64
Fluorometric measurements of conformational changes in glutamate transporters. Proc Natl Acad Sci U S A (2004) 1.61
Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol (2004) 1.61
Excitatory amino acid transporters: keeping up with glutamate. Neurochem Int (2002) 1.61
The chloride permeation pathway of a glutamate transporter and its proximity to the glutamate translocation pathway. J Biol Chem (2004) 1.59
Synaptically released glutamate activates extrasynaptic NMDA receptors on cells in the ganglion cell layer of rat retina. J Neurosci (2002) 1.56
Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci U S A (2001) 1.56
Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol Pharmacol (2003) 1.55
Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. J Neurosci (2002) 1.54
Caveolae--from ultrastructure to molecular mechanisms. Nat Rev Mol Cell Biol (2003) 1.53
Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature (2001) 1.53
The glutamate transporter EAAT4 in rat cerebellar Purkinje cells: a glutamate-gated chloride channel concentrated near the synapse in parts of the dendritic membrane facing astroglia. J Neurosci (1998) 1.51
Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol (1997) 1.51
Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem (1997) 1.51
Glutamate-mediated glial injury: mechanisms and clinical importance. Glia (2006) 1.51
Neuronal glutamate transporters control activation of postsynaptic metabotropic glutamate receptors and influence cerebellar long-term depression. Neuron (2001) 1.50
Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol (1996) 1.50
GAT1 (GABA:Na+:Cl-) cotransport function. Database reconstruction with an alternating access model. J Gen Physiol (1999) 1.46
The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes. Pharmacol Ther (2005) 1.45
Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci (2003) 1.44
Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J Biol Chem (2004) 1.43
Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol (1997) 1.42
Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol (1997) 1.39
Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology (2003) 1.39
A role for caveolae in cell migration. FASEB J (2004) 1.38
Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J Neurochem (2006) 1.35
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology (2003) 1.34
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology (2002) 1.33
The glutamate and neutral amino acid transporter family: physiological and pharmacological implications. Eur J Pharmacol (2003) 1.33
Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J Biol Chem (2004) 1.32
SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci (1999) 1.32
Dynamic regulation of the dopamine transporter. Eur J Pharmacol (2003) 1.32
Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons. J Neurosci (2004) 1.31
Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol Pharmacol (2004) 1.30
Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport. J Neurosci (1999) 1.30
A trimeric quaternary structure is conserved in bacterial and human glutamate transporters. J Biol Chem (2004) 1.29
Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature (2001) 1.29
Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease--an in situ hybridization study. J Neuropathol Exp Neurol (1997) 1.28
Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem (1996) 1.27
Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J Neurochem (2002) 1.24
Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol Dis (2005) 1.23
Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport (1996) 1.23
Electrogenic glutamate transporters in the CNS: molecular mechanism, pre-steady-state kinetics, and their impact on synaptic signaling. J Membr Biol (2005) 1.20
Pentameric assembly of a neuronal glutamate transporter. Proc Natl Acad Sci U S A (2000) 1.18
Glutamate transporter cluster formation in astrocytic processes regulates glutamate uptake activity. J Neurosci (2004) 1.17
Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol (2004) 1.16
A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system. Neuroscience (2002) 1.14
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry (2001) 1.14
Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking. Brain Res Mol Brain Res (2004) 1.13
A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med (2006) 1.12
Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis (2005) 1.12
Tissue specific variants of glutamate transporter GLT-1. FEBS Lett (1997) 1.11
Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics. Glia (2005) 1.11
Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci (2000) 1.10
Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis. Glia (2004) 1.09
A novel sorting motif in the glutamate transporter excitatory amino acid transporter 3 directs its targeting in Madin-Darby canine kidney cells and hippocampal neurons. J Neurosci (2002) 1.09
Role of glial amino acid transporters in synaptic transmission and brain energetics. Glia (2004) 1.06
Post-translational regulation of EAAT2 function by co-expressed ubiquitin ligase Nedd4-2 is impacted by SGK kinases. J Neurochem (2006) 1.06
Regulation of glial glutamate transporter expression by growth factors. Exp Neurol (2003) 1.05
Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J Neurosci (2006) 1.04
Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem (2002) 1.02
Developmental expression of excitatory amino acid transporter 5: a photoreceptor and bipolar cell glutamate transporter in rat retina. Neurosci Lett (2000) 1.02
Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem (1998) 1.73
Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine. J Neurochem (1989) 0.94
The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes. Br J Pharmacol (2011) 0.93
Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice. J Neurosci (1997) 0.85
Links between L-glutamate transporters, Na+/K+-ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin. Neuroscience (2013) 0.82
[(3)H](2S,4R)-4-Methylglutamate: a novel ligand for the characterization of glutamate transporters. J Neurochem (2001) 0.79
Quantitative analysis of in situ hybridization histochemistry. Int Rev Neurobiol (2002) 0.75